Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-22-023776)

Filing Details

Accession Number:: 0001437749-22-023776
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-10-06 18:14:22
Reporting Period:: 2022-10-04

Accepted Time:: 2022-10-06 18:14:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1029125	Panbela Therapeutics Inc.	PBLA	Pharmaceutical Preparations (2834)	870543922

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1652996	T. Michael Cullen	712 Vista Blvd #305 Waconia MN 55387		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-10-04	165,000	$0.00	369,576	No	4	P	Indirect	By Cullen Living Trust Dated April 23, 2009

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Cullen Living Trust Dated April 23, 2009

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants (right to buy)	Acquisiton	2022-10-04	247,000	$0.00	247,000	$0.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
247,000	2022-10-04	2027-10-04	No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	216,811	Direct

Footnotes

Reported securities purchased as one share of common stock and one warrant to purchase one share of common stock for a combined price of $0.30 per share and warrant.